Could Bristol-Myers Squibb Company BMY soon be put on the market for sale as activist investor, Carl Icahn, takes interest in the company? Though it is unclear how big of a portfolio Icahn has bought and Icahn's intention, it is clear that the company is seeing growth after The Wall Street Journal reported the news. Bristol-Myers is currently at $55.37 per share with 1% growth.